Winton Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,884
Closed -$2.77M 802
2024
Q4
$2.77M Sell
6,884
-624
-8% -$251K 0.18% 134
2024
Q3
$3.49M Buy
+7,508
New +$3.49M 0.24% 105
2024
Q1
Sell
-8,521
Closed -$3.47M 891
2023
Q4
$3.47M Buy
8,521
+6,944
+440% +$2.83M 0.25% 58
2023
Q3
$548K Buy
1,577
+327
+26% +$114K 0.05% 219
2023
Q2
$440K Sell
1,250
-10,161
-89% -$3.58M 0.04% 382
2023
Q1
$3.6M Buy
11,411
+298
+3% +$93.9K 0.22% 85
2022
Q4
$3.21M Buy
11,113
+5,574
+101% +$1.61M 0.21% 92
2022
Q3
$1.6M Sell
5,539
-12,597
-69% -$3.65M 0.1% 264
2022
Q2
$5.11M Sell
18,136
-5,414
-23% -$1.53M 0.27% 68
2022
Q1
$6.15M Buy
23,550
+7,753
+49% +$2.02M 0.32% 50
2021
Q4
$3.47M Buy
15,797
+12,962
+457% +$2.85M 0.21% 82
2021
Q3
$514K Buy
2,835
+302
+12% +$54.8K 0.03% 847
2021
Q2
$511K Buy
2,533
+468
+23% +$94.4K 0.03% 910
2021
Q1
$444K Buy
2,065
+89
+5% +$19.1K 0.03% 949
2020
Q4
$467K Sell
1,976
-2,510
-56% -$593K 0.03% 828
2020
Q3
$1.22M Sell
4,486
-12,004
-73% -$3.27M 0.04% 728
2020
Q2
$4.79M Buy
16,490
+14,027
+570% +$4.07M 0.12% 228
2020
Q1
$586K Buy
+2,463
New +$586K 0.02% 983
2019
Q2
Sell
-1,708
Closed -$314K 1293
2019
Q1
$314K Sell
1,708
-288
-14% -$52.9K 0.01% 787
2018
Q4
$331K Buy
+1,996
New +$331K 0.01% 627
2018
Q2
Sell
-1,474
Closed -$240K 1166
2018
Q1
$240K Sell
1,474
-196
-12% -$31.9K 0.01% 1059
2017
Q4
$250K Sell
1,670
-54,967
-97% -$8.23M 0.01% 637
2017
Q3
$8.61M Buy
56,637
+52,675
+1,330% +$8.01M 0.27% 94
2017
Q2
$511K Buy
+3,962
New +$511K 0.02% 500